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Effects of Resveratrol Supplementation on Glycemic Response and Oxidant Status 
in Moderately Exercised Mature Quarter Horse Geldings 
 
Jennie L. Zambito 
 
Resveratrol, a naturally occurring phytocompound is known to exert numerous 
health benefits including improved insulin sensitivity and glucose tolerance, along with 
decreased tissue damage due to reactive oxygen species (ROS).  This compound is 
incorporated in a multitude of supplements targeted to performance horses, yet no 
research in an athletic equine model has been completed to date. Therefore, this study 
was performed to test the hypothesis that resveratrol supplementation would improve 
glucose tolerance and insulin sensitivity, while reducing oxidant damage in an exercising 
model. Six, healthy, fit aged (10.5+1.5yr, ~500kg) Quarter Horse geldings were assigned 
to three treatment groups in a Latin Square random crossover design with one week 
between crossovers. Horses either received no supplementation (control, C) or one of two 
treatments (T); low dose (L, 2.5g of trans-resveratrol) and high dose (H, 5g of trans-
resveratrol) administered on a daily basis for 14 days. Body weights (BW), blood 
samples, and muscle biopsies were collected on day 0 and day 14 of each 
supplementation period. All horses were moderately exercised 3 times a week for 60 
minutes with an average heart rate of 90 bpm. A frequently sampled intravenous glucose 
tolerance test (FSIGT) was conducted on day 10 of supplementation during each 
treatment period.  Feed intake data was collected daily. Samples from day 0 and 14 were 
analyzed for thiobarbituric acid reactive substances (TBARS), while FSIGT samples 
were analyzed for plasma insulin and glucose.  The null hypothesis was rejected when 
P<0.05, and trends were identified when P < 0.10. Minimal model analysis of FSIGT, 
along with evaluation of baseline inulin and glucose concentrations, and area under the 
glucose and insulin curve showed no effect of resveratrol supplementation (P > 0.05). 
Plasma TBARS was unaffected by resveratrol supplementation (P > 0.05) within this 
model. Body weight did not change due to T, yet contrast between C and T displayed 
trends toward increased feed intake as % BW of both hay and concentrate (P < 0.10). In 
conclusion, resveratrol supplementation in the moderately exercised horse does not 
improve insulin sensitivity or glucose tolerance, or overall lipid peroxidation. Increased 
feed intake displayed by T over C may have a potential application for a high 
performance animal. These observations display a need to further evaluate the effects of 
resveratrol in other equine models, and a more in depth assessment of resveratrol within 
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The horse is an extraordinary athlete subjected to numerous stressors during the 
course of exercise, including oxidative stress and inflammation.  During exercise, 
oxidation of energy substrates is critical to provide the working muscles with enough fuel 
to complete the desired task.  As the rate of oxidation increases, the production of 
reactive oxygen species, specifically free radicals, also increases.  Damage to vital tissues 
are caused by free radicals, by destroying cell proteins, fatty acids and DNA1 which can 
result in lameness and an inability to perform due to muscle soreness in horses.  
Antioxidants naturally occurring within the body or supplemented in the diet aid in 
protecting the tissues from the damaging effects of free radicals by inhibiting production 
or up-regulating degradation of free radicals as well as by promoting repair of damaged 
cells or tissues. 2  
At the same time, metabolic syndrome and insulin resistance have been well 
characterized in both performance and non-athletic horses.  Insulin resistance has been 
implicated in the development of debilitating disorders including laminitis and 
osteochondritis3 and is linked to the upregulation of inflammatory pathways.  
Both nutritional and exercise interventions are being researched for their ability to 
lower insulin resistance while acting as an antioxidant.  Resveratrol (trans-3, 4’, 5-
trihydroxystilbene), a phytocompound present in grapes, red wine, yucca, and peanuts,4-6 
has been found to act as a powerful antioxidant and anti-inflammatory agent, along with 
beneficial effects against ageing and metabolic diseases.7 The anti-inflammatory and 
antioxidant characteristics of resveratrol have been studied within rodent and human 
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models;4-6,8,9  however, research in an equine model is severely lacking.  Many nutritional 
supplements fed to performance horses today contain resveratrol, yet information on the 
efficacy of the compound to impact the glycemic response, inhibit the effects of free 
radicals, and reduce inflammation is unknown.  A better understanding of how resveratrol 
contributes to equine health and potential performance could be obtained by evaluating 
various parameters relating to glycemic response and levels of oxidative damage.  This 
data can then be utilized as preliminary evidence to support the use of resveratrol 
supplementation in performance horses or in horses suffering from equine metabolic 




CHAPTER I: LITERATURE REVIEW 
The Athletic Horse  
 The horse is an extraordinary athlete, due to a compilation of physiologic 
adaptations utilized to increase performance.  From a survival standpoint, enhanced speed 
was necessary to escape predators, and increased endurance was required to travel long 
distances to find food or water. Through the domestication of horses, humans were able 
to utilize this athleticism for work, travel and leisure. The various breeds are utilized for 
the areas in which they excel, yet all horses display an ability to run and jump at a much 
higher level than other animals of similar body size. This enhanced athletic ability of the 
horse is due to high maximal aerobic capacity, large intramuscular energy stores, high 
mitochondrial concentration in the muscle, efficiency of gait, and efficient 
thermoregulation.10 All play an integral role in the superior athletic ability displayed by 
the horse, yet for the purpose of this review, only factors influencing aerobic capacity and 
metabolism will be discussed in detail.  
Aerobic Capacity 
 Aerobic capacity encompasses oxygen transport, and movement of oxygenated 
blood to the peripheral tissues for use, and the utilization of oxygen at the muscle. The 
large aerobic capacity in the horse is primarily due to large maximum cardiac output and 
higher hemoglobin concentration.10 Cardiac output is defined as the product of heart rate 
and stroke volume, and is responsible for the amount of blood delivered to the tissues. At 
times of increased oxygen needs, heart rate and stroke volume can increase to partially 




 Oxygen transport depends on the ability to move oxygen from the air to the 
peripheral tissues efficiently. The circulation is responsible for moving oxygenated blood 
from the lungs to the tissues for delivery at a level contingent upon the oxygen carrying 
capacity of the blood. During exercise, when the need for oxygen in the working muscles 
is elevated, the horse increases the amount of circulating red blood cells via splenic 
contraction without a simultaneous increase in plasma volume.11 This increase in red 
blood cells, and thereby hemoglobin, increases the oxygen carrying capacity of arterial 
blood by up to 50% during intense exercise.3 By increasing the amount of oxygen carried 
within the blood, greater amounts of oxygen can be unloaded at the tissues and utilized. 
 Oxygen utilization is achieved during aerobic respiration within the mitochondria. 
Facilitation of increased oxygen delivery to the muscle is achieved by high capillary and 
mitochondrial density, which maximize the effects of increased cardiac output and 
splenic contraction.12 Mitochondria are responsible for providing energy to the working 
muscle cell, and therefore the greater quantity of mitochondria within the muscle, the 
greater the oxidative ability of the tissue. When provided with adequate substrate and 
optimal oxygen delivery, aerobic capacity of the horse is far superior to other animals of 
similar size and stature.10   
Energy Storage  
 Oxidation of carbohydrates and fats provides the main source of chemical energy 
for both resting and working cells. Glucose, an absorbable unit of simple carbohydrate 
metabolism is stored as glycogen within the liver and muscle, with over 90% of total 
body carbohydrate stored within the muscle in horses.7 Movement of glucose from the 
circulation into the cell via insulin signaling is needed to facilitate synthesis of glycogen 
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and storage for later oxidation into ATP.  High intramuscular concentration of energy 
substrates are important for fueling muscle during exercise, as the movement of glucose 
from blood into the muscle and consequently into the mitochondria is only slightly 
(<10%) responsible for the energy utilized during intense exercise.13  Glucose 
metabolism within the muscle differs between fiber types and work load, therefore the 
entry of glucose into the cell is crucial for all types of exercise.  
 
Equine Glucose Metabolism 
 The horse utilizes a range of hydrolyzable and fermentable forage carbohydrates 
as its main source of energy. Pasture is the most common form of habitat and nutrition 
for the horse, however in areas where pasture cannot meet the horse’s nutrient needs such 
as during times of extreme weather, hay, or preserved pasture is often used. Forage must 
be fed at a minimum of 1% of the horse’s body weight per day, and often can be fed at an 
amount to meet the horse’s maintenance energy requirements.14 Approximately 75% of 
plant matter is carbohydrate, which can be divided into two main categories: non-
structural carbohydrates (NSC), and structural carbohydrates.14  It is important to consider 
the seasonal variation of carbohydrate content in pasture when feeding, as 
supplementation or dietary restriction may be necessary for proper maintenance. As 
forages mature from leafy to stemmy stages, the proportion of non-structural 
carbohydrates (such as disaccharides, some oligosaccharides and starch equivalents, like 
fructans) to structural carbohydrates (such as hemicellulose and cellulose) is reduced.15  
Eating large amounts of feedstuffs high in NSCs may cause spillover of non-structural 
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carbohydrates into the hind gut, where microbial fermentation of these nutrients can be 
detrimental to the horse.   
Digestion and Absorption  
 Digestion and absorption of the non-structural carbohydrates should occur in the 
small intestine.  Numerous factors can affect prececal digestibility, such as source, 
processing and amount of starch present, timing of forage feeding, and individual 
differences between horses.14 Initially, gastric acid in the stomach begins carbohydrate 
hydrolysis independent of enzyme activity. Digesta then moves to the small intestine, 
where further digestion is achieved via pancreatic -amylase, and amylopectinase cleave 
-1,4 and -1,6 linkages of amylose and amylopectin respectively, producing 
disaccharides and oligosaccharides.15 These products are then subjected to 
disaccharidases sucrase, lactase and maltase in the brush border, which result in the 
liberation of glucose, fructose and galactose for absorption.16 Glucose absorption occurs 
along the brush border via the Na+/glucose cotransporter type 1 (SGLT1) moving 
glucose into the enterocyte, and facilitative glucose transporters (GLUT) which transport 
glucose through the basement membrane and into the circulation.17,18 For the purpose of 
this review, the effects of glucose in the central circulation and uptake into the tissues 
will be discussed later in detail due to the effects of glucose concentration on insulin 
release. Fructose and galactose do not play an integral role in this response, and therefore 
will not be discussed, although it is important to recognize their presence and need in 





Glycogen Storage and Usage 
 Upon entry into the liver or muscle, glucose can either be stored as glycogen, or 
oxidized as a source of energy for immediate use. Entry into either pathway requires 
glucose to first be phosphorylated into glucose-6-phosphate (G6P) by hexokinase or 
glucokinase in the muscle and liver, respectively. If the body is in a fed state, where 
energy substrates are high, G6P will enter the glycogen synthesis pathway. Main chain -
1,4 linkages between glucose residues are formed via glycogen synthase, and the -1,6 
branch points are formed by glycogen branching enzyme.19 The branched structure of 
glycogen allows for increased solubility and to increase the number of reducing ends that 
are able to react with glycogen synthase and phosphorylase.  
 Glucose molecules will continue to be added to glycogen in the postprandial state 
until glucose and insulin concentrations begin to fall. At this time, glucagon is released, 
and glucose can be liberated from glycogen in both the muscle and the liver via the action 
of glycogen phosphorylase and glycogen debranching enzyme.19 Although the general 
concept is the same, the removal of glucose from storage has differing purposes across 
the tissues. Liver glycogen stores are used to maintain blood glucose; therefore, when 
glucose levels drop, G6P is dephosphorylated by glucose-6-phosphatase, and enters the 
bloodstream.19 Muscle lacks this enzyme, and glucose freed from glycogen will remain in 
the muscle cell, and must be used for intracellular energy.  
 
Glucose Homeostasis 
 Hormonal regulation is central to maintaining blood glucose concentrations at a 
relatively constant level. A balance between insulin, glucagon and other hormones are 
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necessary to metabolic homeostasis. Normal equine blood glucose concentration should 
be within the range of 40-70mg/dL,20 and an inability to maintain this basal level could 
result in a multitude of detrimental changes to overall homeostasis within the body. For 
example, prolonged elevation of glucose concentrations has a toxic effect on cells,21 
whereas low concentrations can produce seizures and disorientation.22  
The effects of these hormones reach far beyond their role in glucose metabolism, 
and many intermediates within these pathways feed into other catabolic and anabolic 
states. A prolonged period of fed or fasting metabolism can cause obesity, and insulin 
resistance, or starvation, respectively.  Achievement of optimal body condition, 
performance and physiologic mechanisms is possible with proper management and 
understanding of the detailed hormone functions within these systems.  
Glycemic Response 
 The ability for a feedstuff to be hydrolyzed, absorbed and released into circulation 
to elevate blood glucose concentration is generally regarded as the glycemic index of a 
feed.15 The time needed for these steps to occur is different among various feeds, and can 
be affected by processing methods, which impact the ability for digestive carbolytic 
enzymes to contact the various polysaccharides within the feed.15 A feedstuff with a 
lower glycemic index will release glucose slowly into the bloodstream over time, 
whereas a high glycemic index feed will release glucose rapidly, causing blood glucose 
concentrations to spike. Any increase in blood glucose concentration above baseline 
concentrations will elicit an insulin release from the pancreas, which is aimed to decrease 
glucose concentrations back to baseline; however, repeated, rapid peaks in glucose and 
insulin can pose health concerns.15,16  
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 Upon elevation of blood glucose concentration, glucose is transported into the 
pancreatic  cell via facilitated diffusion by an insulin independent transporter, GLUT 2. 
The degree to which blood glucose concentration is elevated will be proportionally 
displayed within the pancreatic  cell, and thus will elicit an appropriately large 
response.23  Simply stated, membrane depolarization occurs in response to glucose entry, 
leading to intracellular calcium release, signaling the release of insulin-containing 
secretory vesicles via exocytosis.23 Insulin is then able to reach its target tissues via 
circulation, and elicit glucose uptake into the muscle and adipose tissues to reduce blood 
glucose concentrations.  
Glucose Transport 
 Glucose transport is the rate limiting step of glucose metabolism at the skeletal 
muscle level.22 When insulin reaches the muscle, the hormone binds to the insulin 
receptor, composed of two  and two  subunits, attached by a disulfide linkage, 
resulting in insulin receptor substrate tyrosine kinase activity.24 The insulin receptor 
phosphorylates several intracellular targets which serve as docking sites; the insulin 
receptor substrate family (IRS). These proteins act as a docking site for 
phosphatidylinositol-3 kinase (PI3K), and upon activation, PI3K functions to convert 
phosphatidylinositol-2-phopshate (PIP2) to phosphatidylinositol-3-phosphate (PIP3).25 
Then, PIP3 activates protein kinase B, which functions to recruit vesicles containing 
GLUT 4 to the plasma membrane.25 Facilitated diffusion of glucose can then occur into 
the cell, and in turn will aid in the decrease of blood glucose concentration. The GLUT 4 
isoform is considered to be an insulin dependent transporter,26 due to its reliance on 
hormone signaling to move the transporter to the membrane. The ability for insulin to 
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elicit this response within the cell is dependent on the receptor’s sensitivity to insulin, 
along with the effectiveness of promoting the GLUT 4 translocation to the cell surface. 
 
Insulin Sensitivity and Effectiveness 
 Proper insulinemic response requires both sensitivity of the insulin receptor, and 
movement of GLUT4 to the membrane to facilitate glucose movement into the cell. 
Impairments to either portion of this pathway can cause prolonged, increased levels of 
circulating glucose, leading to an array of health concerns including insulin resistance.27 
Determining an animal’s ability to dispose of glucose at a normal rate is dependent on 
pancreatic responsiveness and insulin sensitivity.28 Understanding the mechanics behind 
glucose tolerance can allow for determination of various supplements, exercise training 
and disease effects on the individual parameters involved in this response.   
 Pancreatic responsivity is defined as the ability of pancreatic β-cells to secrete 
insulin in response to glucose stimuli.28 Inability of glucose to elicit an insulin response 
with enough amplitude to return glucose back to baseline levels can be viewed as 
impairment in this signaling pathway. It is important, however, to note that diminution of 
the insulin response may be due to rapid insulin degradation or neutralization by 
antibodies before the hormone can make contact with its receptor and not due to 
pancreatic responsiveness to stimuli.29  
 Insulin sensitivity is determined by the effect of insulin at the cellular level. 
Interaction of the hormone with its receptor elicits the aforementioned cascade utilized to 
bring glucose into the muscle and adipose tissue. Inability of insulin to elicit this response 
may be caused by unresponsiveness of the receptor or an inability to properly translocate 
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sufficient GLUT4 to the membrane surface, and subsequent decrease in intracellular 
glucose use.27,29 Whole body glucose tolerance is affected by the amount of insulin 
secreted by the pancreas in response to glucose and sensitivity of the skeletal muscle to 
insulin; therefore, both parameters need to be assessed together to gain a full 
understanding of glucose homeostasis.  
Measuring Insulin Sensitivity in Horses 
 Development of an accurate means of measuring and evaluating the relationship 
between glucose and insulin has progressed from a simplistic approach to a 
comprehensive picture. Initially, single, fasting glucose and insulin measurements were 
used to identify any imbalance in these systems.29 Accuracy of this method was 
questioned due to individual variation of these concentrations in a short period as a result 
of stress, feeding or diurnal variation.29,30 Ratios of basal glucose-to-insulin have also 
been utilized, where glucose-to-insulin ratios describe insulin sensitivity, and insulin-to-
glucose ratios describe pancreatic responsiveness to blood glucose.30  Tolerance testing is 
also implemented to gain an integrated understanding of in vivo response to bolus 
glucose doses, exogenous insulin injection, and the combined effect of both on glucose 
homeostasis.  
 Oral glucose tolerance tests (OTT) are best utilized to assess small intestinal 
absorption of glucose, resulting in hepatic glucose uptake and the endogenous release of 
insulin into the body. Utilization of this test should be implemented to address issues of 
malabsorption in the small intestine, and to a limited extent, endocrine function of the 
pancreas and target tissue insulin resistance.31-34  In brief, the test is conducted after an 
overnight fast, and a dose of 1g/kg BW glucose is administered via nasogastric tube. 
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Blood samples are then taken at various timepoints between 0 and 360 min, with peak 
glucose concentration occurring between 90 and 120 min post dosage, and baseline 
concentrations re-established after 4 to 6 h.31, 35, 36 Decreased response to glucose in 
comparison to normal values may suggest reduced pancreatic function;36 however, it is 
important to consider possible shortcomings of this procedure.  Stress of nasogastric 
intubation, delayed gastric emptying, variation in glucose administration rate, and 
reduced intestinal absorption may also impact the validity of the test results.29, 36 
 Intravenous glucose tolerance testing has been widely used to evaluate the 
differences between diet, breed and disease states of various equids.37-39  The variable 
effect of glucose absorption by the digestive tract as seen in the OTT is eliminated in the 
intravenous glucose tolerance test (IVGT).29  The test is conducted by infusing 0.5g 
glucose/kg BW directly into the bloodstream of a fasted animal over a short period of 
time, and collecting blood samples at various timepoints over 5 to 6 h post bolus glucose 
administration.  Glucose utilization and thereby insulin sensitivity can be calculated 
relative to glucose half-life and fractional turnover rate.35  Normal horses should display 
peak glucose concentrations around 15 min after infusion,30 and return to baseline 
approximately one hour after the start of the test.22 Insulin response should parallel 
glucose response curves, where peak insulin concentration should be seen 30 min post 
glucose dose.36 Horses displaying a higher peak glucose concentration, delayed return to 
baseline glucose concentration may be due to impaired insulin release or inhibited 
glucose disposal.30 Unfortunately, with this test, it is only possible to determine if 
impaired pancreatic -cell function is occurring by evaluation of serum insulin 
concentrations. Evaluation of tissue level sensitivity must be evaluated by other means.  
13 
 
  Insulin tolerance tests (ITT) are utilized to assess tissue sensitivity to insulin and 
evaluate the animal’s response to hypoglycemia induced by the exogenous insulin dose.22, 
30 Dosages range between 0.2 to 0.6 IU/kg BW, causing an approximate 50% drop in 
blood glucose from starting values within 20 to 30 min post dose, and a return to fasting 
values within 2 h. 35,  40 If any impairment is present within the test animal, glucose 
concentrations will not fall as dramatically, and return to fasting glucose level will be 
achieved at a faster rate. 20,31 Results of this test are not a comprehensive representation 
of glucose homeostasis as it only address insulin function at the tissue level, and ability 
for the body to recover from hypoglycemia induced by a bolus insulin dose.  
 In all of the above methods, endogenous insulin can fluctuate freely, and thus may 
have an impact on glucose homeostasis during the test. A clamp technique was developed 
in 1966 allowing for plasma glucose to be manipulated to a desired concentration, 
thereby interrupting the negative feedback cycle through which glucose-insulin signaling 
occurs.44 Although this places the animal in a non-physiologic environment, it currently 
remains the most accurate tool used to determine the effects of hyperglycemia and 
hyperinsulinemia on various tissues and pathways affected by these states. 22, 29, 27, 30, 36, 41, 
42 The hyperglycemic clamp causes an acutely elevated glucose concentration held 
constant at a predetermined level to suppress hepatic gluconeogenesis for the duration of 
the test. Glucose infusion rate is therefore a measure of insulin secretion and therefore 
can be utilized to quantify  cell sensitivity to glucose.22, 31  The hyperinsulinemic 
euglycemic clamp supplies steady state insulin concentration during which the rate of 
glucose infusion needed to maintain euglycemia displays insulin effectiveness at the 
target tissues. Both types of clamp provide a unique set of information to aid in the 
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understanding of cellular glucose dynamics, yet a model to encompass physiologic 
responses to glucose tolerance is also useful.  
 Frequently sampled intravenous glucose tolerance tests (FSIGT) combines the 
theories described in the intravenous glucose and insulin tolerance tests by evaluating 
pancreatic insulin secretion and tissue sensitivity in a physiologically relevant situation. 
Procedure for this test involves rapid intravenous infusion of a bolus glucose dose at 
0.33g/kg BW,43 followed by an exogenous intravenous insulin dose at 30mIU/kg of BW 
20 min post glucose dose.20 The goal of this insulin infusion is to elicit a physiological, 
not pharmacological insulin effect, without inducing hypoglycemia.20, 44 Simulation of 
plasma glucose changes when insulin effects are applied can then be utilized to determine 
insulin sensitivity.45   Frequent blood samples are taken after each respective dose, and 
analyzed for glucose and insulin concentrations for later analysis through the Minimal 
Model program (MinMod Millennium).  
 The Minimal Model program is designed to calculate variables used to describe 
factors mediating glucose homeostasis.  This analytical model has been validated within 
the horse to evaluate normal versus disease states, 28, 43-46  and can be utilized to 
differentiate between insulin resistance with or without pancreatic compensation.29 
Interpretation of glucose and insulin dynamics can be accomplished with the use of two 
mathematical models 47 representative of the effect of insulin to increase glucose uptake 
and the effect of glucose to enhance insulin secretion.28 The insulin kinetics model breaks 
down insulin responsiveness to glucose, 48 while the glucose kinetics model utilizes the 
insulin time course response to predict glucose kinetics, thus resulting in a measure of 
insulin sensitivity .47 Parameters of the minimal model of glucose and insulin dynamics 
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consist of insulin sensitivity (Si), glucose effectiveness (Sg), acute insulin response to 
glucose (AIRg) and disposition index (DI), 20, 49 which can be determined by fitting of 
glucose and insulin curves resulting from the FSIGT. Figure 1 describes the various 
compartments used within the minimal model concept to quantify Si, Sg, AIRg, and 
DI.20, 49-51 Five main equations are used to determine these values, all which can be 
calculated using the minimal model. 20, 50, 51  
Glucose effectiveness is an expression of the capacity for glucose to mediate its 
own disposal independent of any insulin concentration change.20,49-51 This value can be 
calculated using the following equation:  
G’(t) = -(X + Sg) x G(t) + (Sg x Gb) 
where G’(t) represents rate (min-1)of glucose clearance from plasma; X represents insulin 
action or the ability for insulin to accelerate glucose disposal at increased levels; G(t) 
represents plasma glucose concentration (mg/dL) at time t, where G(0) is the theoretical 
glucose concentration at time 0; and Gb represents basal glucose concentration (mg/dL) 
as maintained by hepatic production.20 
 Insulin sensitivity (L•mU-1•min-1) values are used to determine the capacity of 
insulin to promote glucose uptake.20  Use of the following equations gives a Si value: 
X’(t) = -p2 x X(t) + (p3 x [I(t) – Ib]) 
Si =p3 /p2 
where X’(t) (min-2) represents the change in insulin action over time; p2 represents rate of 
insulin action decline (min-1) ; X(t) stands for insulin action (min-1), or the acceleration of 
glucose disposal associated with increased insulin concentrations; p3 represents the 
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rate of insulin movement into the interstitial space (min-1); I(t) stands for insulin 
concentration at time t (mIU/L); and Ib represents baseline insulin concentration 
(mIU/L).20,49 Assumptions for this model are X(0) = 0 and [I(t) – Ib] = 0 if I(t) < Ib.20 
Acute insulin response to glucose (AIRg), (mU • min • L-1) enumerates 
endogenous insulin release in response to glucose presence,20 measured prior to 
exogenous insulin administration.49 Calculation of AIRg can be done using the following 
equation: 
AIRg = ∫ [I(t) – Ib] x dt 
where I(t) represents the insulin concentration at time t, and Ib stands for basal insulin 
concentration.20 The above equation was integrated from 0 < t < 10 min in compliance 
with the definition of AIRg proposed by Bergman.20, 51 
 The disposition index (DI), a quantification of pancreatic β cell responsiveness, is 
a measure of absolute insulin action potential attributable to initial insulin response and 
tissue sensitivity.49  The following equation can be used to calculate DI: 
DI = AIRg x Si 
Utilization of the minimal model allows for comprehensive analysis of the 
components affecting glucose disposal, insulin signaling, and the relationship between 
them.51  Practical applications for this method are often used in evaluation disease states, 













Figure 1: Diagram of the minimal model compartments. Variables correspond to 




Factors Affecting Insulin Sensitivity 
 Proper functioning of the physiological system can become compromised or 
enhanced due to numerous factors including, but not limited to, age, breed, nutrition, 
obesity, and exercise.20, 37, 41 Further understanding of the impact these parameters have 
on glucose homeostasis within the horse can allow for manipulation of the system to 
elicit a desired response. Although disruption of normal function can be detrimental, 
knowledge of potential methods to alter glucose and insulin mechanics can have 
implications in disease prevention or treatment, exercise performance, and overall animal 
health.  
 Insulin sensitivity and glucose tolerance change over the course of a horse’s life. 
During fetal development, foals in the second half of gestation have lower serum insulin 
concentrations than mature horses with similar levels of circulating glucose.20 Pancreatic 
β cell response to glucose increases with fetal age;52,53 prior to 230 days gestation 
exogenous glucose administration does not elicit an insulin release. 53 Maturation of 
pancreatic β cell function occurs over time, where insulin concentrations increase 24 to 
48 hours post parturition,52,54 and increase to normal, mature levels at approximately 3 
months after birth.55 Numerous studies across various models have shown that insulin 
sensitivity decreases with age,44, 56-59  and the rate at which this decline occurs is 
dependent on environment, diet, genetics, and several other factors.60 Potential age-
related changes to insulin sensitivity may be due in part to factors affecting the 
hypothalamic pituitary adrenal axis, as changes in circulating levels of corticosteroids can 
impact insulin effectiveness over time.61  
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 Differences in insulin sensitivity have also been noted across various equine 
breeds. Ponies are typically less insulin sensitive than horses, 62 thereby having a slower 
glucose disposal rate.63, 64 This characteristic makes pony breeds a good insulin 
insensitive model for evaluating the effects of long term hyperinsulinemia or 
hypyerglycemia on body systems and tissue function. 41, 64 Donkeys appear to have less 
sensitivity to insulin than ponies or horses; after an oral glucose tolerance test, donkeys 
and ponies have similar insulin concentrations, but donkeys had elevated glucose levels 
as long as 6 h post glucose administration. 34 Draft breeds may have an improved insulin 
sensitivity over light breeds, as displayed by the increased rate of glucose infusion needed 
to maintain euglycemia for Belgian horses over Quarter horses during a clamp 
procedure.65,66 More knowledge is needed to determine exact breed differences and 
consideration should be taken when making conclusions based on insulin or glucose 
measurements across breed types.  
 Dietary patterns play a key role in maintaining glucose homeostasis from many 
different angles. Chronic positive energy balance can contribute to obesity, and insulin 
resistance (IR), and despite the strong linkage between these two conditions,67 they can 
occur independently of one another. 69 Management of nutrients in equine feedstuffs, 
including fat, protein, and starch can prevent the negative repercussions associated with 
overfeeding.  
 Insulin resistance (IR) is defined as the reduced cellular ability to respond to 
insulin and transport glucose from the bloodstream into the muscle and other tissues. 22 In 
horses, IR is commonly associated with equine metabolic syndrome (EMS), 20, 41, 69, 70 
pituitary pars intermedia dysfunction, or Equine Cushing’s Disease, 37, 70 and some types 
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of laminitis. 41, 71, 72  Chronic hyperglycemia resulting from IR can cause toxic effects on 
the structure and function of many organs, including the pancreatic β cells.21 Asplin and 
others demonstrated the ability to induce laminitis with prolonged infusion of insulin to 
achieve a hyperinsulinemic, hyperglycemic status,30, 64 similar to the onset of laminitis 
observed with EMS.  One potential mechanism for glucose toxicity can be explained via 
the formation of excess reactive oxygen species (ROS) which over time results in chronic 
oxidative stress, decreased insulin gene expression, and impaired insulin secretion.73 
Damage or exhaustion of the pancreas has also been demonstrated in other models,22 with 
potential implications within equine metabolic syndrome.37  
 Concentrates are commonly fed to horses for many reasons. Ease of feeding 
provides appeal to horse owners, while increased energy composition of the feed can be 
applicable to the performance horse. Feeding concentrates as a supplement to forage 
increases energy and nutrient consumption for horses with needs above maintenance 
levels; however, overfeeding diets with high energy content can lead to obesity. In 
horses, high fat diets can be utilized to increase caloric load without inducing a high 
glycemic response67 and subsequent bouts of excitability.74 Enhancement of anaerobic75 
and aerobic exercise performance76 has also been observed, however consideration must 
be taken into the amount and necessity of fat supplementation.  As the most energy dense 
macronutrient (9 kcal/g), diets high in fat can cause weight gain and indirectly result in 
IR due to increased adiposity.74  Excess fat can be stored intramuscularly, and may play a 




 Excess protein within the diet is not only costly, but can negatively impact insulin 
sensitivity.67 Several studies have shown that acute elevations in plasma amino acid 
concentrations decreases glucose disposal during a hyperglycemic euglycemic clamp 
trial,77-79 and excess leucine alone has minimized insulin mediated glucose uptake.80 A 
possible mechanism for decreased glucose transport displayed  in response to excess 
amino acid presence may be due to the elevated inhibitory phosphorylation of IRS-1 
achieved by mammalian target of rapamycin, or mTOR.81 IRS-1 inhibition thereby 
decreases PI3K, and negatively impacts the recruitment of GLUT4 through this 
pathway.81 Also, due to the glucogenic or ketogenic abilities of amino acids, and 
therefore the ability for protein to contribute to energy storage, proteins should be fed at 
maintenance requirements.82 
 High intakes of non-structural carbohydrates have been associated with 
circulatory, hormonal, digestive, and metabolic changes,83 leading to the development of 
various disorders such as IR, metabolic syndrome, and laminitis.84 Changes in post-
prandial glucose and insulin concentrations seen with diets high in starches and sugar are 
much greater than those associated with diets of forage alone or those supplemented with 
fat.83, 85, 86  
 Prolonged levels of elevated glucose concentrations not only induce obesity, but 
also result in insulin insensitivity due to over-stimulation of the pancreas as well as tissue 
unresponsiveness due to hyperinsulinemia. This decrease in glucose clearance from the 
bloodstream causes conflicting signals to be sent through the tissues. On a circulatory 
level, the body responds to the increased levels of glucose by stimulating more insulin 
release; however, the tissues are not able to move glucose efficiently, and thus have to 
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utilize other fuel sources. Often, this is manifested through fatigue or muscle wasting, due 
to the lack of glycogen stores within the muscle and utilization of protein for energy, 
respectively. Exercise along with dietary intervention can be implemented to counteract 
and prevent this condition.  
 
Effects of Exercise on Glucose Metabolism 
 
Physical exercise can be an important adjunct in mediating the glucose-insulin 
response in healthy, aged, and diseased animals. Similar to insulin, exercise increases the 
rate of glucose disposal into the contracting skeletal muscle cells by utilization of a 
different signaling pathway. A single bout of exercise has the ability to increase rates of 
glucose usage 87, 88 and increase insulin sensitivity at the muscle level,89 with effects 
lasting for hours after exercise has ended.90-92 Both short- and long-term exercise effects 
on glucose uptake and disposal have important roles in relationship to chronic metabolic 
control and acute regulation of glucose homeostasis.26    
Acute Exercise  
 In the contracting muscle, the need for metabolic fuel is partially met though an 
increase in glucose uptake and utilization. Initially, this phenomenon was displayed in the 
masseter muscle; as chewing occurred, venous outflow showed decreased glucose 
concentration, suggesting a mechanism for glucose uptake during contractions.93 Over 
time, more information was collected to suggest potential methods for this increased 
disposal. Evidence has been found to suggest that in conjunction to increased glucose 
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uptake during exercise94, 95 acute exercise results in increased insulin sensitivity restricted 
to the exercised muscles.  
 The major mechanism by which glucose disposal is increased during exercise is 
through the recruitment of GLUT4. The exercise-induced translocation of this transporter 
is due to an increase in recruitment in association with the non-junctional transverse 
tubules upon contraction, rather than an increase in amount of GLUT4 protein present in 
the cell, or an increase in other GLUT isoforms.26,96-98 Although insulin concentrations 
during exercise are typically reduced, 67 increased blood flow to the muscle during 
exercise may also increase the amount insulin presented to the muscle receptors, 
therefore causing the increased translocation of GLUT4.99 The effects of exercise and 
insulin can produce additive effects on GLUT4 movement,100-102 yet independent 
function is also displayed, suggesting the existence of different intracellular pools of the 
transporter that respond to each respective stimulus.99, 103, 104  
 Post exercise increases in insulin sensitivity are typically characterized by 
elevated rates of basal and insulin mediated glucose uptake for several hours.101, 105 
Although the exact mechanisms in this response are unknown, replenishment of muscle 
glycogen stores, influence of endocrine mechanisms, and serum contents may elicit these 
effects.26 Degree of glycogen depletion can mediate the rate and duration of muscular 
glucose disposal after exercise due to the need to increase glycogen stores for the next 
bout of exercise.26 Insulin signaling is not altered by exercise as a single bout does not 
impact insulin receptor affinity, or tyrosine-kinase receptor signaling;106-108 however, 
increased presence of the hormone due to increased circulating levels of glucose from 
hepatic gluconeogenesis elicit the glucose disposal.  Resulting hypoxia from exercise 
24 
 
markedly amplifies glucose signaling in the muscles, by use of a signaling pathway 
which bypasses the insulin receptor, IRS-1, and the subsequent activation of PI3K in 
hypoxic conditions.109, 110 Utilization of these mechanisms can be beneficial to the horse 
with hyperglycemia, as exercise can provide a transient decrease in blood glucose levels. 
Repetition of exercise bouts can elicit a larger, more prolonged response which can be 
instrumental in management of IR and long term improvement of glucose tolerance. 
Exercise Training  
 The beneficial effects of exercise training may be due to the overlapping short 
term effects of each individual bout of exercise along with changes in gene transcription 
levels. Increased mRNA levels of insulin receptor, IRS-1, MAP kinase,111 and GLUT4 
have been observed after exercise training in both healthy and insulin resistant models.112 
Expression of the GLUT4 gene is also seen in trained athletes, in association with 
increased in insulin mediated glucose disposal.113, 114  Comparison of an animal’s 
response to an acute bout of exercise pre and post training can provide a comprehensive 
picture of the alterations seen to glucose metabolism. Implications for this type of 
program can be useful to determine if long term training effects can be influential in 
addressing symptoms associated with IR horses.  
The Exercising Equine Model 
  Although evaluations of the effects of exercise on metabolic parameters are useful 
in determining the horse’s ability to handle and recover from acute bouts of exercise, 
determination of overall body status changes in an exercising model are also important. 
Exercise can be performed at varying intensities, and monitored using numerous 
parameters including heart rate (HR), length of exercise, and time spent at each gait. 82 
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Understanding the physical and metabolic demands of low, moderate, and high intensity 
exercise can be utilized to provide insight on the effects of supplementation.  
 Workload categories for horses have been established by evaluating the 
relationship between oxygen consumption and energy expenditure. Amount of energy 
utilized during exercise is dependent on the duration and intensity of the exercise bout.82 
While duration is easy to quantify, intensity is often difficult to measure, as numerous 
factors can influence this parameter including ground resistance, incline, speed of 
movement.82 In regard to performance, degree of collection, height of jumps, and weight 
pulled or carried can greatly impact the workload performed by the horse,82 and thereby 
alter the metabolic demands of the body.  
 Oxygen utilization and heart rate are closely correlated, therefore making it 
possible to determine approximate energy expenditure from heart rate.115 Due to this 
relationship, heart rate can be used to assess the workload performed by the horse, and is 
an integral tool utilized in the development of exercise programs. Heart rate during 
exercise is measured in order to properly evaluate the workload, as mean heart rate is 
used to determine exercise intensity. Light, moderate, heavy and very heavy exercise 
categories encompass varying athletic events, and tasks equine athletes are asked to 
perform, with mean heart rates for each bout at 80, 90, 110, and 110-150 bpm, 
respectively.83 Duration of exercise is also important to consider, as the amount of time 
spent at a given level of work can greatly alter energy expenditure and other factors 
including reactive oxygen species (ROS) generation, which can induce changes both 




Effects of Exercise on Oxidant Status 
 
Aerobic metabolism, the body’s most efficient means of energy production, 
utilizes oxygen as the final electron acceptor in mitochondrial electron transport chain 
(ETC). Although most oxygen that enters the body is utilized in this manner, a small 
portion is susceptible to enzymatic alteration, direct chemical reactions, or modification 
by the cytochrome P450 superfamily, which utilizes oxygen for substrate oxidation.1, 116 
Combined with the oxygen that has not been fully reduced to water in the ETC, which 
amounts to approximately 1-2% of total oxygen intake,  these compounds are referred to 
as reactive oxygen species (ROS).117 Accumulation of these compounds can be utilized 
for signaling or inflammatory responses within the body; however, prolonged elevated 
amounts can cause detrimental effects to lipid membranes, proteins, or nucleic acids. 
Oxidant status in the body is a constantly changing balance between reactive species and 
the defense systems utilized to keep their effects at bay. Conversion of ROS into 
effectively neutral compounds via the anti-oxidant defense system allows the body to 
cope with increased levels of ROS, and prevents against some of the damaging effects of 
these molecules on cells.1, 116 Evaluation of this balance can provide insight to whole 
body oxidant status, as well as the degree of damage resulting from ROS. 
ROS Production 
Formation of ROS can occur in a multitude of different ways, including both 
radical and non-radical derivatives of oxygen. Molecular oxygen in the ground state is a 
bi-radical, containing two unpaired electrons in the valence shell, sharing the same 
spin.118  This similarity causes oxygen to react with one electron at a time. A free radical 
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is an independent species with one or more unpaired electrons, formed by the loss or gain 
of a single electron. These molecules tend to be highly reactive, either accepting or 
donating electrons rapidly in order to achieve a more stable state of being. Reactive 
oxygen species is an inclusive term used to describe some free radicals, such as 
superoxide and hydroxyl, but also include some non-radicals such as hydrogen peroxide 
and hypochlorous acid.1 All radicals are ROS, however not all ROC are radicals, yet their 
reactivity allows them to easily strip electrons from other molecules, producing another 
free radical in the process.1 Generation of ROS can be seen throughout the cell, however 
the most important source of production is the ETC.  
 During normal metabolic function, the mitochondria utilize different states of 
respiration. Alterations in substrate availability and metabolic demands impact the 
changes between the different states of respiration. State 3 and 4 of respiration are 
commonly examined to further understand the impact of the ETC on cellular metabolism 
and oxygen utilization.1 State 3 represents the maximal oxygen consumption rate needed 
to meet metabolic ATP demands, whereas state 4 respiration is associated with 
maintenance ATP production costs.116 State 4 is also characterized by low ADP amounts, 
as the body is able to keep up with energy production; however, despite the lower flow of 
electrons through the chain, this state produces an abundance of superoxide radicals. This 
production occurs due to leakages caused by improper function of b-type cytochromes, 
like ubiquinone, which transports electrons from complex I and succinate to complex III, 
complex I constituents, and overall damage to mitochondrial organization.116 Other 
methods of ROS production include xanithine oxidase, electron leakage from nuclear or 
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microsomal membranes containing cytochrome b5 and P-450, inflammatory response 
leading to increased activation of NADPX oxidase,1 along with many others.  
Functions of ROS 
Through the conversion of oxygen into water, various intermediates are formed, 
most of which contribute to the ROS pool.  Most commonly superoxide, the hydroxyl 
radical, and hydrogen peroxide are measured due to their prevalence within this 
conversion and their role within the body. Despite the negative connotation associated 
with ROS, a certain level of intracellular production is necessary to activate growth, 
differentiation, proliferation and apoptotic programming.119 Superoxide, a highly reactive 
molecule, is often formed first from leaky channels within the ETC, which can then be 
dismutated spontaneously or by superoxide dismutase (SOD) into hydrogen peroxide.120 
Hydrogen peroxide is a non-radical and a weak oxidant, with a long half-life, permitting 
diffusion across cell membranes, and interaction with many different cellular molecules 
allowing for the activation of a variety of signaling pathways.2 Redox regulation, such as 
the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) transcriptional 
activators, rely on signaling from ROS to relieve inhibition from IkB proteins, thereby 
allowing for transcription of several antioxidant enzymes including copper-zinc and 
manganese SOD.119 Mitochondrial biogenesis and metabolic changes seen in response to 
exercise may be coordinated through ROS signaling of transcription factors and 
coactivators.119 Although the exact role of ROS in many signaling pathways is unknown, 
measurement of ROS activity and presence is critical to understanding the function of 





 Measurement of ROS can be challenging, due to their highly reactive nature and 
relatively short time of existence. Direct and indirect detection and fingerprinting can be 
used to determine the presence of ROS, measure the concentration of specific ROS 
species, and assess damage caused to cellular molecules. Direct measurements can be 
made through electromagnetic spin resonance used to detect the presence of an unpaired 
electron using a magnetic field. This method can also be utilized to detect changes in 
transition metal ions used in ROS production.121 Although this method can be used in 
vivo, it has low sensitivity, therefore making it difficult to detect highly reactive radicals. 
Spin trapping is often used to overcome this, as it is highly sensitive. Reactive oxygen 
species are allowed to react with selected molecules to produce a more stable compound 
that can be detected and measured reliably.122 When used in combination with one 
another, these methods can provide a big picture view of ROS within an in vivo model.  
  Indirect methods of detection are used to quantify their concentrations, with 
various methods applied dependent on the ROS to be evaluated. Superoxide detection 
methods include reductions of nitroblue tertazolium or cytochrome c, and oxidation of 
lucigenin.121 Unfortunately, reduction methods display low specificity and sensitivity, as 
many compounds besides superoxide can reduce these molecules while lucigenin 
oxidation is subject to artifact production, and care should be taken when analyzing 
results from these methods.121 Hydrogen peroxide can be measured reliably using 
horseradish peroxidase assays utilizing a specific reaction to produce a fluorescent 
product for detection. Also, probes for tissue detection of ROS can be used; however, 
caution should be taken to ensure accumulation of the probe does not occur in a particular 
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cell compartment.122 Concentration of the hydroxyl radical is most commonly determined 
using the tryptophan reaction or utilizing the conversion of DMSO to methane gas and 
calculating the rate of change relative to radical presence. Hydroxyl radicals are detected 
using the tryptophan method by measuring the formation of 5-hydroxytryptophan 
luminescence induced by multiphoton excitation.123  
 Fingerprinting is an effective means utilized to determine the reactions of ROS 
with cellular components due to their characteristic end products. Proteins, lipids, and 
nucleic acids are the main targets for ROS damage. Damage to proteins is primarily 
quantified via amino acids with reactive carbonyl groups as they are the most easily 
measured experimentally.122 Measurement is determined by the interaction of oxidized 
protein molecules with dinitrophenylhydrazine, utilizing a fluorescent or radiochemical 
method of analysis. Although this method is reliable, the tissues are susceptible to 
proteolysis and other altering reactions that may skew results.122 Lipid peroxidation is the 
most widely measured form of ROS fingerprinting, as many of the assays are easy to use 
and provide good results. Loss of unsaturated fatty acids can be measured through high 
performance liquid chromatography, while peroxide assays can be conducted for 
glutathione peroxidase, cyclooxygenase, and many more.122 End-product measurements 
are also used to gain a broader view of overall lipid peroxidation, such as thiobarbituric 
acid reactive substances assays. Nucleic acid damage can be quantified using purine and 
pyrimidine base modification via the detection of 8-hydroxydeoxyguanosine, formed in 
the presence of a hydroxyl radical.122 Strand breakage can also be quantified, as oxidation 
of the strands will cause cleavage, resulting in detectable fragments. Deoxyribose 
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oxidation is not easy to measure, and should not be used as a sole indicator of damage, 
since multiple products are produced. 
 Although ROS production is necessary within the body for proper signaling and 
other homeostatic functions, excessive production can elicit damaging responses.1 
Potential mediation beyond naturally occurring defense mechanisms in the body can be 
employed to buffer or prevent these changes. From an exercise perspective, reduction in 
excessive ROS production and damage could result in increased performance due to 
decreased insult to cellular components.119 Phytochemicals, compounds which naturally 
occur in plants, may have an impact on overall health and are commonly fed to horses as 
a supplement in hopes of preventing ROS damage.4 Although some of these compounds 
are used extensively, knowledge of their function, efficacy, and safety are limited, and 




Naturally, plants synthesize a wide array of compounds which have potential health 
benefits when eaten. Resveratrol (trans-3, 4’, 5-trihydroxystilbene, figure 2), a 
phytocompound found most commonly in grapes, red wine, yucca, and peanuts, 4-6 has 
been found to act as a powerful antioxidant and anti-inflammatory agent, along with 
having beneficial effects against ageing and metabolic diseases.6 Administration of 
resveratrol has been shown to cause a reduced amount of edema,123 increased muscle 
strength and endurance,8, 124-127 along with protecting skeletal muscle from the deleterious 
effects of oxidative stress through alterations in metabolism8, 123, 125-127 and reduced 
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protein catabolism.8, 124-127 Additionally, within skeletal muscle, resveratrol has been 
found to increase insulin stimulated glucose transport9 and improve glucose 
homeostasis.8 By limiting the detrimental effects on metabolism combined with 
reductions in tissue injury, increased exercise performance may then be expected to occur 
in response to resveratrol supplementation in horses.  
Synthesis and Structure 
  Resveratrol is a phytoalexin, meaning synthesis of the compound can be induced 
by microbial infections, ultraviolet radiation and exposure to ozone.128 Grapes are the 
primary source of naturally occurring resveratrol,129 with concentrations of the compound 
is found in the leaf epidermis and the skin of grape berries, but not within the flesh. 128-130 
Stilbene synthase, the terminal enzyme in the production pathway is activated in response 
to exogenous stress factors, ultra-violet radiation and chemical signals from  
pathogenic fungi.130 Levels of resveratrol peak approximately 24 h post stress exposure, 
and decline 48-72 h later due to the activation of catabolic stilbene enzymes.130 
Concentration of resveratrol in grapes is dependent upon maturity and variety of the 
grape, along with duration of stress exposure.Grape leaves reach concentrations ranging 
50-400µg/g fresh weight, while fresh grape skin content ranges 50-100µg/g .128 
Resveratrol can occur in multiple forms, both of which are counted in these 
concentrations. 
 Resveratrol exists in two isoforms, trans- and cis-, each having their own 
properties and functions. Although the cis conformation may possess numerous health 
benefits, it is not widely studied at this time.131 Plants can also synthesize stillbenoid 
glucosides, forming cis- and trans- resveratrol 3-O  glucoside,129 which when cleaved 
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can produce a free glucose molecule. Resveratrol can also be obtained through organic 
synthesis; trans-resveratrol is most often formed first, and when exposed to ultra violet 
irradiation changes into the cis conformation.130 Research on the biological properties of 
resveratrol such as bioavailability and function were limited until the compound could be 
synthesized, as pure extraction from the grape skin and leaves is difficult to achieve.  
Bioavailability and Metabolism 
 Bioavailability of a nutrient is defined by the amount available to the target tissue 
after administration, including absorption, distribution, and metabolism of the compound. 
Resveratrol absorption from the intestine is rapid,132-135 allowing for distribution to 
various organs, primarily the liver, kidneys, brain, lungs, and muscle.135, 136 Absorption of 
resveratrol is not greatly impacted by the vehicle in which it is administered. In humans, 
resveratrol is most commonly consumed in red wine, but can also be found in grape juice 
and vegetable homogenates.137 Although resveratrol content can vary depending on 
previously mentioned variables, a previous study held resveratrol concentration constant 
among different matrices to determine absorption rate.137 The matrix used to deliver the 
compound does impact total resveratrol when administered utilizing the different forms 
of adminsitration.137 In order to travel through the body, resveratrol must be bound to 
protein or become conjugated, primarily into resveratrol-3-glucoronide or resveratrol-3-
sulfate,  to remain at elevated concentrations in the serum due to its low water 
solubility.138 Albumin is thought to be one of the main plasma protein transporters of  
unconjugated resveratrol due to its physical properties allowing it to bind to hydrophobic 
compounds. 139, 140  The compound is also shown to interact with lipoproteins in a lipid 








 Figure 2: Trans-resveratrol (trans-3, 4’, 5-trihydroxystilbene).129 
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its selectivity and affinity to protein transporters, which can aid in tissue recognition of 
the molecule. 
Upon absorption, delivery of protein bound or conjugated resveratrol to the 
tissues occurs, with the liver having the highest accumulation of the compound.128,136 
Uptake of resveratrol into the liver occurs via passive diffusion, and carrier mediated 
transport. Utilization of radiolabeled resveratrol allowed for the examination of time, 
dose, and temperature dependencies of resveratrol uptake into the organ, finding that 
carrier facilitated transport is primarily used to allow for efficient and specific uptake of 
resveratrol.142 The liver seems to be a reservoir of resveratrol and its conjugated 
metabolites, resulting from metabolism both in the intestine and the liver. The function of 
this pool is not entirely understood; however, it is thought to be partially responsible for 
the prolonged effects of resveratrol after a bolus dose. Detectable levels of resveratrol can 
occur as early as 15 min post resveratrol administration, with peak concentrations 
occurring 30 min after dosage.136 Although free resveratrol content begins to decline 1 h 
post-dosage,143 resveratrol metabolites remain in the circulation for longer periods of 
time. A second resveratrol peak occurs approximately 6 h post administration, due to 
enteric recirculation of conjugated metabolites. The presence of these metabolites is 
known to aid in the elevation of detectable levels of resveratrol in the blood over time,128, 
136, 144 which may contribute to the efficacy of resveratrol within the body; however, the 
exact function of these structures remains to be determined. It is important to note the 
effects of resveratrol and the time course during which the free and conjugated forms can 
be detected may be dose dependent, which will be later discussed in detail. 
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 Removal of resveratrol from the body is accomplished mainly through renal 
excretion.  Decreasing concentration of radiolabelled resveratrol metabolites in the 
kidneys strongly suggests their primary role in elimination of these compounds from the 
body.133, 134 Some elimination may occur through biliary binding pathways, although 
minimal research has been conducted in this area.128  Resveratrol-3-sulfate and 
resveratrol-3-glucoronide are found in the urine of rodents and humans;135,143 however, 
species variation should be taken into consideration, along with differences due to dose 
rate and concentration. Free resveratrol has not been found in murine or human urine,143 
suggesting that the majority of free resveratrol is either utilized by the peripheral tissues 
or conjugated and stored by the liver or excreted.  
Functions  
  Resveratrol is currently known for its antioxidant, anti-inflammatory, anti-cancer 
and chemopreventative abilities. Interest in resveratrol began when an inverse correlation 
was found between red wine consumption and cardiovascular disease occurrence.129  The 
compound was first thought to be the biologically active ingredient in red wine in 
1992,145 causing extensive research into the effects of resveratrol within the body. 
Currently, resveratrol is known to impact numerous mechanisms and pathways within the 
body, including inhibition of lipid peroxidation, free-radical scavenging, alteration of 
eicosanoid synthesis, modulation of lipid metabolism, improvement of insulin sensitivity, 
anti-inflammatory activity and estrogenic activity.9,128-131  For the purpose of this review, 
lipid peroxidation, modulation of lipid metabolism and improvement to insulin sensitivity 
will be the primary focus.  
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 Resveratrol prevents the peroxidation of membrane lipids by ROS.129, 146, 147 
Resveratrol acts as a scavenger of free radicals, preventing the oxidation of membrane 
lipids.146 Maintenance of structural integrity of the plasma membrane is crucial to proper 
cellular function, and can have detrimental effects on exercise performance. Preventative 
effects are not limited to the muscle cells; it has been shown that resveratrol has 
prevented damage due to peroxidative stress in dopaminergic neuronal and hepatic 
cells.146, 147 The compound has also been found to prevent metal induced lipid 
peroxidation within microsomes and low-density lipoproteins (LDL).148 Alterations in the 
conformation of LDLs can increase the amount of circulating fatty acids in the 
bloodstream, due to structural changes in apo B, thereby affecting catabolism by the B/E 
receptor system,121 aiding in the predisposition of the animal to numerous metabolic 
diseases. 
 Modulation of lipid metabolism can also occur due to resveratrol 
supplementation. Resveratrol has been shown to increase silent information regulator 2 
homolog (SIRT) 1 and peroxisome proliferator -activated receptor (PPAR)- coactivator-
1 (PGC1) in muscle,123 resulting in an altered metabolism displaying an increased 
sensitivity to insulin, along with a preferential switch to fat as a fuel source.149 Increases 
in fatty acid transporter content, PPAR- pathway activation, and fat oxidation enzymes 
are responsible for this shift. The glucose sparing effect of resveratrol allows for more 
glucose to be stored as glycogen, and a decrease in fat available for deposition in the 
adipocytes. Reduction in circulating fatty acids in the blood stream combined with 
improved insulin sensitivity makes resveratrol a potential mediator for type 2 diabetes in 
humans, and a potential area of interest for equine metabolic syndrome.  
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  Resveratrol has been shown to improve insulin resistance via enhancement of 
enzyme activity involved in glucose metabolism, along with increasing the insulin 
sensitive cell’s ability to respond to the hormone. In a streptozotocin-nicotinamide-
induced diabetic rats, resveratrol supplemented orally at 5mg/kg BW for 30 days was 
able to alter activities of key carbohydrate metabolism enzymes such as hexokinase and 
pyruvate kinase, which returned back to normal concentrations, allowing for normal flux 
of the substrate through this catabolic pathway.150  Reduction of circulating glucose is 
achieved by enhancement of GLUT-4 translocation, perhaps due to resveratrol’s actions 
on PGC-1.151, 152 In mice, resveratrol supplementation at 400mg/ kg BW daily increased 
levels of PGC-1 acetylation, leading not only to an increase in glucose transport, but 
also to an induction of oxidative phosphorylation genes and mitochondrial biogenesis.152   
Increasing the cells ability for glucose uptake and metabolism can aid to alleviate 
hyperglycemia along with ensuring substrate availability in the cell for utilization and 
storage.  
  Increased circulating levels of ROS, excessive circulating free fatty acid levels, 
and hyperinsulinemia, can all cause oxidative stress, resulting in chronic inflammation, 
insulin resistance, and decreased exercise performance.29 Resveratrol acts to diminish 
oxidative stress via induction of mitochondrial MnSOD expression and activity.153 A 
potential mechanism of action for this result begins with resveratrol increasing the SIRT 
1 to NAD+ ratio, leading to an increase in FOXO3, resulting in increased MnSOD 
activity. Other enzymes, such as CuZn SOD, glutathione peroxidase, and catalase display 





 Despite the extensive research conducted across murine and human models, an 
effective dose for resveratrol has yet to be established. Administration rates, 
concentrations, and durations are widely varied, making it difficult to determine 
appropriate means through which beneficial effects can be seen. Fresh grape skin 
contains 50-100mg resveratrol/g,154 making the content of naturally occurring beverages 
containing the skin vary greatly as well.  In red wine, the range of detectable trans-
resveratrol spans from non-detectable levels to 14.3mg/L (62.7M), with reported health 
benefits seen at average levels, 1.9 + 1.7mg/L (8.2 + 7.5M).130 During early resveratrol 
trials, wine of a known content was used as the main method of dosage. Even then, 
duration and concentration of supplementation varied greatly; 86g resveratrol/kg BW 
for a single dose, or 43g resveratrol/kg BW once daily for 15 days.132-134 The trend 
continues through much of the literature utilizing a more “natural” form of resveratrol, 
and has transcended through present day.  
 The development of organic synthesis of trans-resveratrol opened the door to 
further research on the compound without concern of competition or conflicting results 
due to competition of other flavinols present in wine.  Despite this advancement, 
resveratrol could then be administered in greater doses, over greater time periods, along 
with the option of injectable administration.  Intragastric administration to mice has been 
supplemented from values ranging to 0.228/kg BW to 60 mg/kg BW, making it difficult 
to elucidate the appropriate dose on a weight basis.133, 135, 149  In human studies, 
supplementation levels have been reported at 0.03mg/kg BW to 0.35mg/kg BW, with 
many other values in-between.137  Duration of supplementation also varies tremendously; 
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some literature touts the benefits of a loading dose of high concentration, followed by a 
lower maintenance dose, while others remain at a specified concentration over time.  
Single dose administration seems to be utilized only during trials for which absorption, 
metabolism, or clearance are the primary areas of evaluation.  
Resveratrol in the Equine Industry 
Regardless of level, resveratrol supplementation appears promising.  Many nutritional 
supplements fed to performance horses today contain resveratrol.  Lack of regulation in 
this area of equine nutrition allows for extreme flexibility in the content of each 
supplement and the claims made in regards to their suggested benefits to the horse.  Many 
companies have begun to incorporate resveratrol into their products at varying 
concentrations, usually in conjunction with other compounds with suggested health 
benefits.  Utilization of this compound in the athletic horse can lead to a decrease in ROS 
damage, therefore decreasing the detrimental effects seen with prolonged exercise at 
varying intensities.  
Along with its popularity within the equine performance horse industry, resveratrol 
also has a potential role for the metabolic syndrome animal. Maintenance of these 
animals is often difficult, with the primary goal of treatment to reduce BW and return 
insulin sensitivity and glucose tolerance to a normal level to prevent laminitis and 
worsening of the condition.  Due to the positive benefits in other models, resveratrol 
supplementation may be beneficial to the treatment of this condition by increasing 
glucose transport, shifting to fat as the preferred metabolic fuel source, and increasing 
oxidative capacity through mitochondrial biogenesis.152  
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 Despite the current popularity and the vast potential uses for resveratrol within the 
equine industry, no published research is currently available within an equine model. 
Without this data, speculation and testimonials from consumers are used to evaluate the 
function of resveratrol within the horse and market the compound to the equine industry.   
Evaluation of both an athletic and EMS model are needed to fully elucidate the effects of 
resveratrol within the horse. A better understanding of how resveratrol contributes to 
equine health and potential performance could be obtained by evaluating various 
parameters relating to glycemic response, levels of oxidative damage, and inflammation, 
with consideration given to the findings of previous studies in other models.   
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STATEMENT OF PROBLEM, OBJECTIVE, AND HYPOTHESIS 
In both human and rodent models, research has been conducted to determine the 
effects of resveratrol. Diets high in this phytocompound are synonymous with good 
health, with applications in various models and disease states.  Specifically, resveratrol 
has been found to have both antioxidant and anti-inflammatory properties, while at the 
same time improving cellular glucose dynamics.  While numerous equine performance 
supplements contain resveratrol, no research has been conducted utilizing an equine 
model. 
Therefore, the objectives of the proposed study are to utilize a mature, athletic 
horse model to (1) examine the ability of resveratrol to act as an antioxidant molecule to 
protect the body against oxidative damage and lipid peroxidation, (2) determine the effect 
of resveratrol supplementation on basal plasma insulin and glucose concentrations, as 
well as glucose and insulin dynamics during a frequently sampled glucose tolerance test. 
The hypotheses of this study were that resveratrol supplementation would (1) 
improve oxidant status within the moderately exercised equine model by reducing the 
level of lipid peroxidation within the body (as measured by TBARS), and (2) increase 
insulin sensitivity and glucose tolerance as displayed by the Minimal Model parameters.  
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CHAPTER II: MATERIALS AND METHODS 
  
The West Virginia University Animal Care and Use Committee approved all 
methods and procedures used in these experiments.  
Animals and Diet 
 Six, healthy, fit, mature Quarter Horse geldings (equus caballus) were used in this 
study (10 + 1 yr). The Quarter Horse breed was used due to its popularity within the 
United States, versatility among various performance events, and industry impact due to 
the large population within the targeted marketing group.  Prior to use for this project, all 
horses were used for the Equestrian Technology course offered by West Virginia 
University, where they were exercised lightly 3 to 4 times per week for approximately 1 
hour per week, mainly at the walk and trot, by riders of all experience levels. All horses 
began the study with a body condition score (BCS) of 5.5 + 0.5, which was maintained 
through the duration of the trial.  Body weights (BW) were taken on day 0, and 10, and 
14 of each treatment period and are further described later. 
 Horses were brought in one week prior to the start of the study to allow for dietary 
adjustment from pasture.  Geldings were housed in 3.05 x 3.05 m box stalls at West 
Virginia University Reedsville Experiment Farm, with turnout in pairs 1 h per day in a 
sand arena, to ensure dietary control through the course of the study.  Horses were 
offered a commercially available concentrate ration (Southern States Legends Show and 
Pleasure Pellets, Richmond, VA) at 0.5% BW and grass hay (West Virginia University 
Agronomy Farm, Morgantown, WV) at 1.75% BW divided into two feedings daily.  The 
ration was formulated to meet National Research Council82 recommendations for mature 
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horses in moderate work. Hay and concentrate samples were analyzed by a commercial 
laboratory (Equianalytical laboratories, Ithaca, NY).  A summary of feed analyses can be 
found in Table 1.  On an as-fed basis, concentrate provided 2.75 Mcal/kg and hay 
provided 1.97 Mcal/kg.  All feedstuffs were weighed prior to feeding, and any refusals 
were recorded to determine actual daily intake.  Horses were provided ad libitum access 
to water. Geldings were accustomed to the barn, and general laboratory procedures. 
Resveratrol Supplementation 
 Horses were assigned to treatment groups using a Latin Square crossover design 
(Figure 3).  Treatment groups included control (C, no supplementation), low 
supplementation (L) of 2.5g trans-resveratrol once daily, and high supplementation (H) of 
5g trans-resveratrol once daily.   
Resveratrol is generally regarded as safe (GRAS).  The supplement was compounded 
(Equithrive, Lawless, KY) with a concentration of 1g of 99% pure micronized resveratrol 
per 10g polyethylene glycol-based paste, therefore horses received a total of 25g or 50 g 
of product in the L and H dosage groups, respectively.  The resveratrol micronization 
process ensures that 90% of particles measure less than 10 m, and when combined with 
polyethylene glycol, makes the compound more water-soluble and thus should increase 
bioavailable.  These levels of supplementation reflect values currently used in rodent and 
human research, calculated on a basis for a 500 kg average horse to receive 5mg/kg and 
10mg/kg.  Metabolic BW (MBW, defined as BW(0.75)) was calculated 82 to ensure 
supplementation levels were adequate in relationship to metabolism of the compound for 
species used in previous research. Average BW for each species was determined as; rat: 
230 g,155 mouse: 20 g,155 human: 70 kg,156 horse: 500kg.82  When compared on a MBW
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Table 1: Nutrient analysis (DM basis, Equi-analytical, Ithaca, NY) for hay and 
concentrate, fed at levels in accordance with NRC recommendations, to mature Quarter 
Horse geldings performing moderate intensity exercise to for a total of 9 weeks; 1 week 
acclimation prior to study, 3 periods of 2 week supplementation, and 1 week washout 






basis, dosages utilized for this study are applicable to those commonly seen in literature 
for other models.  
Supplementation was conducted over 14 d, with a 7 d washout period in between 
each treatment.  During the treatment period, horses were moderately exercised three 
times per wk as per the protocol detailed below.  
Exercise Protocol  
 In order to assess the effect of resveratrol on an exercising conditioned model, 
horses maintained a moderate level of activity through the study.  Turnout was allowed 
for ~2 h per day during treatment and washout periods.  Horses were exercised 3 times 
per week for 60 min, with at least one day of rest in between exercise bouts.  In 
accordance with the NRC, moderate intensity exercise is defined as 3-5 h per week, with 
a mean heart rate of 90 beats/min, during which 30% of exercise time should be spent at 
the walk, 55% at the trot, and 10% at the canter.82  Using these guidelines, the following 
exercise protocol described in Table 2 was followed for the duration of the study, with a 
total time at the walk, trot and canter being 18, 30, and 12 min, respectively. 
An equine heart rate monitor (Polar Equine, Lake Success, NY) was utilized to 
monitor heart rate during exercise bouts.  Heart rate was monitored starting 
approximately 10 min prior to exercise to allow acclimatization of the system, and to 
ensure the horse was at rest before starting to work, and continued through the entire 
exercise set.  Gait speed was adjusted to maintain heart rate within the target range.  All 
horses were ridden by a set of riders with similar skill sets, and all exercise bouts were 
overseen by one individual to ensure continuity through the study.  All horses remained 












Figure 3: Latin square crossover design used to rotate control (C, no supplementation), 
low resveratrol supplementation (L), and high resveratrol supplementation (H) between 6 
mature Quarter Horse geldings during 3 treatment periods of 2 weeks each. Between each 
treatment period a 1 week washout period was allowed to pass before the next treatment 
was administered.  
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Table 2: Exercise protocol designed to mimic moderate intensity exercise in accordance 












 Blood Samples and Muscle Biopsies 
  Blood samples were collected into sodium heparin tubes (Vacutainer, Franklin 
Lakes, NJ) on d 0 and 14 of supplementation within 24 h of an exercise bout for later 
analysis of TBARS concentration.  Samples were pulled, placed immediately on ice, and 
transported to the West Virginia University Main Campus for further processing. 
Samples were centrifuged at 3000 x g for 1  mi n, and stored at -2    C until analysis.  
Muscle tissue biopsies were collected on day 0 and 14 of each treatment period.  A 
Bergstrom biopsy needle was used to collect tissue samples from the middle gluteal 
muscle.157  All geldings received Xylazine (0.5mg/kg) sedation and were given Lidocaine 
anesthesia (8-10cc of 20mg/50mL concentration) at the biopsy site ~10 minutes prior to 
sampling.  Samples were dissected into 0.25cm pieces, immediately flash frozen in liquid 
nitrogen, then stored at -80   C until later analysis for resveratrol concentration (results not 
shown).  
Frequently Sampled Intravenous Glucose Tolerance Test (FSIGT) 
 All horses were subjected to a FSIGT on d 10 of resveratrol supplementation 
during each treatment period. Concentrate and hay feedings were withheld for the 
duration of the test, and at least 12 h had passed since the last feeding.  The protocol for 
this test was determined from previously published methods, described below.20  
 Geldings were weighed using an electronic scale and catheterized (Abbocath, 14g, 
5.5 in, Abbott Laboratories, Abbott Park, IL) using aseptic technique and Lidocaine 
anesthesia between 0730 and 0830.  Horses were paired randomly to allow for test 
staggering. Baseline blood samples (~25ml) were collected 30 minutes prior to the start 
of each test, at approximately 0900, 0930 and 1000, respectively.  A glucose bolus of 
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0.3g/kg BW (dextrose solution, 50%, Phoenix Pharmaceutical, Inc, St. Joeseph, MO) was 
infused via catheter over a 2 min period.  Twenty min after the glucose dose, an insulin 
bolus (Humulin R, Williow Birch Pharmaceutical, Inc, Taylor, MS) of 30mIU/ kg of BW 
was administered via catheter.  The primary function of the insulin bolus was to 
administer a physiological, not pharmacological, dose of insulin, to prevent prolonged 
hyperglycemia, and prevent hypoglycemia.20 
 The test was conducted over ~3 h, during which blood samples (~25ml) were 
collected at -30, 0, 1, 2, 3, 4, 5, 6, 7, 8, 10, 12, 14, 16, 19, 22, 23, 24, 25, 27, 30, 35, 40, 
50, 60, 70, 80, 90, 100, 120, 150, and 180 min post glucose administration.  Between 
each sample, the catheter and extension set were flushed with 15-20cc heparinized 
normal saline to prevent clot formation within the line, and avoid contamination of 
successive samples.  Samples were placed in serum separator and sodium 
fluoride/potassium oxalate tubes (Vacutainer, Franklin Lakes, NJ), and stored on ice until 
centrifugation at 3000 x g for 10 min.  Sodium fluoride/potassium oxalate additive was 
used to prevent further glycolysis in samples to be later assayed for glucose 
concentration.  Aliquots were taken from both tubes, and stored in microcentrifuge tubes 
at -2    C until analysis.  For insulin concentration, serum aliquots were measured in 
duplicate via a commercially available radioimmunoassay (Coat-A-Count, Siemens, Los 
Angeles, CA), as directed by the package insert. After the samples were decanted, they 
were placed in a gamma counter (Perkin Elmer, Wallac 1470 Wizard Auto Gamma-
counter, Waltham, MA), where each replicate was counted for 1 min.  Plasma glucose 
was measured in duplicate using a commercially available kit (Autokit Glucose, Wako 
Diagnostics, Richmond, VA) adapted to a 96 well plate.  In brief, 9µL of sample, 
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standard or control were pipetted into a 96 well plate.  Standards provided in the kit were 
diluted to include concentrations which more accurately reflect those seen in horse 
blood.158  Then, 3   L of buffer solution was added to each well, followed by 2  mi n 
incubation at 37   C.  The plate was then read on a UV spectrophotometer (Spectramax 
Plus 384, Molecular Devices, Sunnyvale, CA). Each of these kits have been previously 
validated for use in the horse.2, 158  The accepted replicate coefficient of variation was 5% 
and 10% for glucose and insulin concentrations, respectively.158  
Thiobarbituric Acid Reactive Substances (TBARS) 
 Plasma samples collected on d 0 and 14 of each supplementation period were 
assayed for presence of TBARS.  A commercially available kit (TBARS microplate assay 
kit, Oxford Biomedical Research, Oxford, MI) was used in accordance with the kit insert.  
In brief, 25  L of standard or sample was pipetted into a microcentrifuge tube, followed 
by 25  L of indicator solution or acid reagent.  Samples were incubated at  5   C for 15 
min, then centrifuged at 100xg for 15 min, and loaded onto a 96 well plate.  Absorbance 
was read at 532nm (Flexstation3, Molecular Devices, Sunnyvale, CA).  Samples 
containing acid reagent were used as a blank, and were subtracted from those containing 
indicator solution to determine malondialdehyde (MDA) concentration.  Samples were 
assayed in duplicate. 
Data Analysis  
 Area under the curve (AUC) for insulin and glucose was calculated via the 
trapezoidal method utilizing the data points from the FSIGT.158 Glucose effectiveness 
(Sg), insulin sensitivity (Si), acute insulin response to glucose (AIRg) and disposition 
index (DI) were calculated using minimal model software (MinMod Millennium, Version 
52 
 
6.02) as previously reported.20  Any animal which did not fit the model with an R2 > 0.9 
was removed prior to statistical analysis.  
 Results are expressed as mean + SE.  Data were analyzed using the GLM 
procedure of SAS (SAS Institute, Inc., Cary, NC, 2006) where horse was a random 
variable, and fixed variables included treatment, and period along with all possible 
interactions.  The null hypothesis was rejected at α= . 5 f or main effects and 
interactions, with trends defined when P < 0.10.  Treatments were further separated using 
Tukey’s test where appropriate. Contrasts were also conducted within Proc GLM to 
examine differences between control (C) and treatment (T, both low and high). 
 Body weights were averaged to determine mean weight across each T period.  
Daily hay and concentrate intake were evaluated in relationship to percent (%) BW.   
Plasma TBARS concentrations were evaluated individually for d 0 and 14 samples.  
Plasma TBARS data were also evaluated as normalized by subtracting the difference of d 
14 and d 0 concentrations.  
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CHAPTER III – RESULTS 
 
Body Weight and Feed Intake 
  
 Results for mean BW were 541.81, 540.46, and 539.47 + 1.95 kg for C, L, and H 
respectively.  No effect of treatment (P = 0.72), period (P = 0.36), or treatment by time 
interaction (P = 0.29) was found.  
Feed intake results were calculated based upon mean values of daily hay and 
concentrate intake, expressed as percent of BW consumed.  Upon evaluation of hay 
intake, trends were noted with regard to treatment (P = 0.097, Figure 3) and period (P = 
0.094; Figure 4), but no interactions were observed (P = 0.180).  Hay intake averaged 
1.66, 1.71, and 1.69 + 0.01 % BW in kg for C, L, and H respectively (Figure 3).   The 
contrast between control and treatment groups showed a trend (P = 0.053), where 
treatment resulted in an increased intake of 0.08% BW.  Concentrate intake expressed as 
percent of BW displayed no significant effects of treatment (P = 0.122, Figure 5), period 
(P = 0.145) or interaction (P = 0.217).  Contrast evaluation between control and treatment 
groups revealed a trend (P = 0.053), with treatment resulting in increased concentrate 
intake of 0.016% BW (Figure 5).  
TBARS 
Resveratrol treatment had no effect on plasma TBARS concentration after 14 d of 
supplementation (P = 0.61; Figure 6).  Period also did not have an effect on plasma 
TBARS concentration (P = 0.83) and no interaction was noted (P = 0.99).  Plasma 
TBARS normalized for d 0 concentration also did not differ between treatments (P = 




Figure 3: Hay intake expressed as % of BW (kg) of mature Quarter Horse geldings (n = 
6, mean + SE) in relation to resveratrol supplementation at low (L) or high (H) dosage, or 
no supplementation (control C). Each period lasted 2 weeks.  Trends are denoted with 
brackets and symbols, where P < 0.10. Contrasts are defined as C versus treatment (L and 






Figure 4: Hay intake expressed as % of BW (kg) of mature Quarter Horse geldings (n = 
6, mean + SE) in relation to period during resveratrol supplementation at low (L) or high 
(H) dosage, or no supplementation (control C). Each period lasted 2 weeks.  Trends are 





Figure 5: Concentrate intake expressed as % of BW (kg) of mature Quarter Horse 
geldings (n = 6, mean + SE) in relation to resveratrol treatment over 3 periods, lasting 2 
weeks each.  Trends are denoted with regard to contrasts, which are defined as C versus 












Figure 6: Plasma TBARS concentrations (mean + SE) for 6 mature Quarter Horse 
geldings on d 14 of supplementation with low (L) or high (H) dose of resveratrol or 
control (C, no supplementation). Plasma TBARS is expressed as malondialdehyde 
(MDA) equivalents. No trends or significant differences are noted for treatment (P = 




 There were no differences in baseline insulin concentrations between treatment 
groups (P = 0.26), period (P = 0.99), or interactions (P = 0.36).  Baseline plasma glucose 
also did not differ in regards to treatment (P = 0.89), period (P = 0.56), or interaction (P = 
0.34; Figure 7 and 8).   
A representative glucose and insulin curve for C, L, and H treatment can be found 
in Figures 9, 10, and 11, respectively.  Curves were accepted for graphical representation 
based upon their fit into the minimal model (R2 > 0.9). 
There were no differences between treatment (P = 0.56), period (P = 0.41), and no 
interaction (P = 0.20) were noted with regard to Sg.  Similarly, Si was not affected by 
treatment (P = 0.59), period (P = 0.14) or interaction (P = 0.79).  Treatment, period, nor 
interaction had an effect on AIRg, where P = 0.35, 0.98, and 0.43 respectively.  
Disposition index (DI) was also not affected by treatment (P = 0.93) or period (P = 0.19) 
and no interaction was displayed (P = 0.84).  No differences between treatment (P = 
0.84), period (P = 0.32), or interaction (P = 0.95) were noted with regard to AUC of 
insulin.  Likewise, AUC of glucose did not differ in regards to treatment (P = 0.80), 












Figure 7: Baseline insulin concentration (mean ± SE) after an overnight fast in six 
mature Quarter Horse geldings supplemented with resveratrol (low or high dose), or 
control (no supplementation).  No significant effects or trends of treatment (P = 0.26), 















Figure 8: Basal glucose concentration (mean ± SE) in six mature Quarter Horse geldings 
sampled after an overnight fast and supplemented with resveratrol (low, L, or high, H, 
dose), or control (C, no supplementation).  No effects or trends of treatment (P = 0.89), 













Figure 9: Mean glucose and insulin concentrations (mean + SE) from a frequently 
sampled intravenous glucose tolerance test (FSIGT) for the control (C, no 
supplementation) horses (n=6) over 3 periods lasting 2 weeks each are displayed.  Data 













Figure 10: Mean glucose and insulin concentrations (mean + SEM) from a 
frequently sampled intravenous glucose tolerance test (FSIGT) for the low (L) dose 
resveratrol supplemented horses (n=6) over 3 periods lasting 2 weeks each are displayed.  






















Figure 11: Mean glucose and insulin concentrations (mean + SE) from a 
frequently sampled intravenous glucose tolerance test (FSIGT) for the high (H) dose 
resveratrol supplemented horses (n=6) over 3 periods lasting 2 weeks each are displayed.  




 Figure 12: Basal glucose (Gb) concentrations (mean + SE) from a frequently 
sampled intravenous glucose tolerance test (FSIGT) were calculated based on control (C, 
no supplementation), low resveratrol supplementation (L) or high resveratrol 
supplementation (H).  Basal glucose is utilized conjunction with the minimal model 




Table 3: Least squares means + SE for Minimal Model variables and area under 
the curve (AUC) for glucose and insulin in regard to control (C, no supplementation), low 
(L), or high (H) dose resveratrol supplementation in 6 mature Quarter Horse geldings in 
response to a frequently sampled intravenous glucose tolerance test (FSIGT). 
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CHAPTER IV – DISCUSSION 
 
This work presents the results from a controlled study in which six moderately 
exercised mature Quarter Horse geldings were supplemented with resveratrol to 
determine if treatment affected glycemic response and oxidant status.  
Resveratrol supplementation administered during this study was compounded 
with polyethylene glycol. Although the C group (no supplementation) did not receive any 
vehicle supplementation, energy substrates present in this compound add a negligible 
amount to overall dietary components, and thus should not have had an effect on body 
condition or energy status between C and T groups.  
Body Weight and Feed Intake 
  Prior to the start of the study, horses were housed in an approximately 12 acre 
pasture, and were utilized in West Virginia University’s Equestrian Technology course.  
Horses were exercised lightly, mainly utilized for beginner to intermediate riding classes, 
3 times per week.  As an athletic horse, feed intake is important to ensure digestible 
energy needs are met, especially for horses with little preference for forage.  Contrast 
between C and T demonstrate a potential use for resveratrol to increase feed intake in the 
moderately exercised equine athlete.  Increased levels of forage may provide a potential 
benefit to the horse, as increased forage intake can lead to increased energy substrate 
from hindgut fermentation and perhaps even an elevated hydration status.159 A period 
effect was noted, with low hay consumption in the first period which may be attributable 
to preference for pasture previously consumed over the hay being offered in the initial 
days. Also, human error may have been a factor, as collection of daily refusals may have 
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differed slightly from person to person.  This could provide a potential benefit to the 
athletic horse. While, the current aim of the study was not to evaluate effects effects of 
resveratrol on body mass or composition, an increased intake attributable to 
supplementation was noted. Within a moderate body condition, resveratrol has no effect 
on body weight, but may have some use in increasing feed intake in the exercising horse, 
although intake was minimal in comparison to overall daily intake. 
TBARS 
 Resveratrol supplementation at low and high levels did not have an effect on 
plasma TBARS (MDA concentration) in plasma. Other markers of oxidant status such as 
glutathione, glutathione peroxidase, and nitric oxide were considered for this study, 
however due to kit inconsistency with equine tissue and blood samples, they were not 
used for this study. Still, speculation into the validity of the TBARS test must be 
considered. Plasma TBARS is utilized to determine lipid peroxidation through the entire 
body; however, the limitations with this assay must be noted. TBARS utilizes MDA, a 
by-product of lipid peroxide to determine the amount of oxidation that occurred. 
Oxidative stress has been shown to occur with specific modes of exercise, yet severity 
and level of tissue damage have not always been consistent, even when similar exercise 
and collection protocols are used.160 Large variation within this assay for equine models 
has been noted numerous times, 117, 160, 161 with pre-exercise ranges measuring from 66 to 
1048 nmol/L,161 and an apparent CV of  >40% .160   Variations between studies including 




 Elevated levels of plasma and serum TBARS have been observed after strenuous 
exercise;165,166 yet, other research has shown long term exercise and acute physical 
activity have not altered plasma TBARS concentration.167 Prolonged low-medium 
intensity exercise has been the most frequently used exercise type to induce marked 
oxidative stress in humans. 168, 169 In half marathon runners, an increase in plasma 
TBARS of 600nmol/L after 40 minutes exercise at 40% VO2max was seen,178 but no 
increase in TBARS was noted after a full marathon was completed.171  Horses that 
completed a simulated race of 1000 + 200 m at an approximate speed of 16 m/s displayed 
an increase in plasma TBARS (P < 0.01),161  and lipid peroxidation was higher in horses 
finishing an 80 km endurance race when compared to those having finished only 21 
km.117 While these results suggest that exercise should increase plasma TBARS 
concentration as a reflection of increased lipid peroxidation, this study did not display a 
similar result. During this study, horses were exercised at a moderate intensity during 
each period. Although the exercise protocol was designed to be challenging to the horses, 
the study design was not to determine effects of resveratrol on tolerance to an acute 
exercise bout, but rather to determine if treatment would be beneficial to the conditioned 
athletic horse. Marketing of resveratrol is currently aimed at the performance horse, with 
claimed applications to those horses exercising at a moderate level, therefore; in order to 
determine resveratrol effectiveness at this level of performance, exercise intensity was 
held constant through the study. Perhaps if a more strenuous exercise test was included 
with either an increased intensity, duration or both had been implemented, an increase in 
plasma TBARS would have been observed.  
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  Literature mainly reports MDA concentration within plasma or serum,172 yet not 
in skeletal muscle, which may provide a more accurate depiction of lipid peroxidation 
occurring at the tissue level. Consideration must be given to the collection methods for 
muscle tissue, as the biopsy procedure may increase damage to the sample. In 
comparison to blood parameters, there are few studies utilizing muscle currently 
available, with inconclusive results. In sedentary rats a slight increase in TBARS has 
been shown in response to exhaustive exercise,164, 173 yet others have shown light to 
moderate acute exercise bouts have not altered TBARS concentration at the tissue level, 
without comparison to blood values.174   Further research is needed to validate testing 
techniques, especially in an equine model and thus, TBARS was not evaluated in muscle 
samples.  
 Sampling time after exercise may also affect reported TBARS concentrations. 
Mixed information is available regarding the rates of production and clearance of TBARS 
from the body, making sampling difficult. Human strength training studies commonly 
sample 24 and 48h post exercise165, yet other studies have shown decreases after an acute 
exercise bout as soon as 30 m post exercise, with returns to baseline ~1 h after 
exercise.165 Equine studies report varying sampling times as well, with samples taken 
during exercise117 as well as anywhere from 5 min161 to 16 h 160 and as far out as 2 wk 
post exercise. 175 During this study, samples were collected ~24 h after an exercise bout 
to be assayed for TBARS concentration. Intensity and duration of exercise may not have 
been sufficient to elicit a detectable change in TBARS during this timeframe, or TBARS 
may have returned to baseline by sample time. It is possible if samples had been collected 
closer to the completion of exercise, or if an acute exercise bout had been conducted, 
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differences may have been seen. Therefore, further work needs to be done to determine if 
resveratrol has an effect on lipid peroxidation during or immediately following an acute 
exercise bout.  
 Evaluation of other markers may have provided a more selective view of the 
function of resveratrol within the horse, but for the purpose of this study, the TBARS 
assay was to be used as an informative comprehensive parameter as to the effects of 
resveratrol supplementation in an exercising athlete. Along with the limitations 
mentioned above, assessment of the antioxidant enzyme pathways present in the body 
were not measured, and therefore their contribution to preventing lipid peroxidation 
cannot be determined. Resveratrol may impact these pathways as well, and further 
information needs to be collected to elucidate its role for the equine athlete in various 
types of exercise.  
Glucose Tolerance and Insulin Sensitivity 
 Previously, resveratrol has been shown to enhance insulin stimulated glucose 
transport, via up-regulation of GLUT 4, and improved glucose tolerance.8 Data from this 
study shows resveratrol supplementation has no effect on glucose tolerance and insulin 
sensitivity represented through Minimal Model analysis, nor baseline insulin and glucose 
concentrations. Causes for this discrepancy may be due to the model utilized for the 
study, along with body condition of the horses. Individual variability with regard to 
treatment must also be considered, as each horse’s response to treatment may have been 




 Both single bouts and prolonged repetitive aerobic exercise has been shown to 
increase insulin sensitivity and glucose tolerance through sensitization of target tissues to 
insulin, along with increased translocation of GLUT 4 via enhanced cellular 
signalling.112-114  In the moderately exercised fit horse, optimum insulin signaling 
pathways should already be in place, thereby making changes to an optimum system 
difficult to produce. An increased presence of mitochondria within the cell due to 
exercise-induced mitochondrial biogenesis make the muscle cell more energetically 
efficient, while allowing for increased cellular oxidative respiration.176 Having these 
systems already in place and being conditioned to exercise leaves little room for 
resveratrol to impact these pathways. Perhaps, if an obese or unfit model was utilized, 
placed into a similar study and evaluated for increased insulin sensitivity and glucose 
tolerance, different results may have been displayed.  Obesity is seen as an increase in 
body condition score, which has been proven to decrease insulin sensitivity, thereby 
impacting glucose metabolism.8 Obese horses were found to have a lower Si and relied 
primarily on Sg for glucose disposal, rather than insulin signaling pathways.20 This 
disease state rather than an athletic model may be a potential niche for resveratrol 
supplementation from a glucose tolerance standpoint, due to its potential ability to 
increase insulin sensitivity and increase effectiveness of this mechanism.150 Resveratrol 
may impact various parameters of the Minimal Model, including Si, AIRg and DI for its 
properties relating to increasing tissue sensitivity to insulin, enhancement of pancreatic -
cell function, and the body’s ability to mediate its own insulin response.  
At the same time, resveratrol is known to up-regulate SIRT1 gene expression and 
down regulate PPAR, together which influence the utilization of fat as an energy 
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substrate,  along with inhibition of inflammatory status, both of which may help to 
modulate the confounding aspects of insulin resistance seen with obesity.123, 152, 157 
Increasing oxidation of lipids as a fuel source may also be beneficial to the endurance 
athlete, which may be a potential model for further investigation, while reduction in 
inflammation may prove useful in athletic horses experiencing osteoarthritis and other 





Resveratrol supplementation in moderately exercised horses resulted in few 
apparent effects.  Trends toward increased feed intake expressed as a percent of BW from 
resveratrol supplementation may be cause for further investigation for the performance 
animal; however, it is important to consider the small amount of feed intake seen in 
regard to resveratrol supplementation when compared to the total amount of intake per 
day. Resveratrol supplementation has no effect on glycemic and insulinemic responses as 
tested by a FSIGT, along with baseline insulin and glucose concentrations, in this 
exercising equine model. Plasma TBARS was also unaffected by supplementation; 
however, a more in depth evaluation of the actions of resveratrol in the exercising model 
is needed to discern its functions among antioxidant enzyme activity.  From this study, 
the marketing of resveratrol as a supplement to increase glucose tolerance and reduce 
ROS damage in performance horses is not supported. Evaluation of resveratrol within a 
different athletic model, such as endurance exercise or ability to tolerate acute exhaustive 
bouts of exercise, with regard to fat metabolism, oxidant status, and inflammation may 
uncover other beneficial functions of resveratrol not assessed here. Therefore, further 
research is needed to more thoroughly examine the possible effects of resveratrol 
supplementation in the horse.  
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